润都股份：公司1类创新药盐酸去甲乌药碱注射液，目前仍在中国国家药品监督管理局的药品注册审评阶段

Core Viewpoint - The company, Rundu Co., Ltd. (002923.SZ), is currently in the drug registration review phase for its innovative drug, Sodium Deoxycorticosterone Injection, and is progressing normally despite inquiries about a pause in drug evaluation [2] Group 1 - The company confirmed that the Sodium Deoxycorticosterone Injection is still under review by the National Medical Products Administration of China [2] - The company will adhere to information disclosure regulations and will provide updates on any significant developments [2] - The inquiry from investors was regarding the reasons for the reported pause in drug evaluation, which the company clarified as not applicable to their situation [2]